Bioceres Crop Solutions Corp. (NASDAQ:BIOX – Get Free Report) has received an average rating of “Buy” from the six ratings firms that are presently covering the firm, Marketbeat reports. Four analysts have rated the stock with a buy recommendation and two have given a strong buy recommendation to the company. The average 1 year price objective among brokerages that have covered the stock in the last year is $8.63.
Separately, Oppenheimer reduced their price objective on Bioceres Crop Solutions from $8.00 to $7.00 and set an “outperform” rating for the company in a report on Tuesday, April 22nd.
Check Out Our Latest Stock Report on BIOX
Bioceres Crop Solutions Stock Performance
Bioceres Crop Solutions (NASDAQ:BIOX – Get Free Report) last issued its quarterly earnings data on Wednesday, May 21st. The company reported ($0.02) earnings per share (EPS) for the quarter, topping the consensus estimate of ($0.10) by $0.08. The firm had revenue of $59.60 million during the quarter, compared to analysts’ expectations of $61.80 million. Bioceres Crop Solutions had a negative return on equity of 2.36% and a negative net margin of 2.14%. Sell-side analysts forecast that Bioceres Crop Solutions will post -0.05 earnings per share for the current fiscal year.
Hedge Funds Weigh In On Bioceres Crop Solutions
Institutional investors have recently made changes to their positions in the stock. Jones Financial Companies Lllp raised its holdings in shares of Bioceres Crop Solutions by 3,535.8% in the first quarter. Jones Financial Companies Lllp now owns 5,490 shares of the company’s stock worth $25,000 after acquiring an additional 5,339 shares during the last quarter. Bank of America Corp DE increased its stake in Bioceres Crop Solutions by 186.8% in the fourth quarter. Bank of America Corp DE now owns 5,735 shares of the company’s stock valued at $35,000 after purchasing an additional 3,735 shares during the last quarter. Jump Financial LLC acquired a new position in Bioceres Crop Solutions in the fourth quarter valued at $72,000. Avanza Fonder AB acquired a new position in Bioceres Crop Solutions in the first quarter valued at $72,000. Finally, PDT Partners LLC acquired a new position in Bioceres Crop Solutions in the first quarter valued at $81,000. 17.68% of the stock is owned by institutional investors and hedge funds.
Bioceres Crop Solutions Company Profile
Bioceres Crop Solutions Corp., together with its subsidiaries, provides crop productivity solutions. It operates through Seed and Integrated Products, Crop Protection, and Crop Nutrition segments. The Seed and Integrated Products segment provides seed traits, germplasms, and seed treatment packs for healthier, and higher yielding crops.
Featured Articles
- Five stocks we like better than Bioceres Crop Solutions
- Golden Cross Stocks: Pattern, Examples and Charts
- Analyst Downgrades Joby, But Overlooks Major Regulatory Wins
- The Top 3 Healthcare Dividend Stocks to Buy and Hold
- U.S. Steel Stock Burns the Bears With Surprise Upside Move
- How to Use the MarketBeat Stock Screener
- Lululemon, UNH, Enphase: Bad News, Good Opportunity?
Receive News & Ratings for Bioceres Crop Solutions Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Bioceres Crop Solutions and related companies with MarketBeat.com's FREE daily email newsletter.